CDC issues Request for Proposal to develop new serology test for Herpes Simplex Virus

The Centers for Disease Control and Prevention (CDC), the Office of Science (OS) in late December 2022 issued a Broad Agency Announcement (BAA) for the competitive selection of research proposals,ContinueContinue reading “CDC issues Request for Proposal to develop new serology test for Herpes Simplex Virus”

New Clinical Study for Broad spectrum anti-viral to treat HPV, Mpox, and possibly herpes

Hyundai Biosciences have applied for a clinical study in Korea to test the efficacy of CP-COVO3, a new candidate treatment for viral infections, on HPV. This antiviral agent, developed inContinueContinue reading “New Clinical Study for Broad spectrum anti-viral to treat HPV, Mpox, and possibly herpes”

Important Win for Herpes Advocacy: FY 2023 Congress Budget Update

Herpes Cure Advocacy celebrates and thanks the US House of Representatives for their prioritization of federal action for Herpes Simplex Virus cure, treatment and prevention in the FY 2023 HouseContinueContinue reading “Important Win for Herpes Advocacy: FY 2023 Congress Budget Update”

Possible herpes keratitis cure takes another step: BDGene of China applies for Orphan Drug Designation at the FDA

Chinese company BDGene from Shanghai continues to lead in the global race for a herpes keratitis cure. The highly anticipated treatment, BD111 has reached a big milestone as it appliedContinueContinue reading “Possible herpes keratitis cure takes another step: BDGene of China applies for Orphan Drug Designation at the FDA”